Status: current, Primitive. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4453731000168117 | tafamidis (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4453741000168114 | tafamidis | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tafamidis | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| tafamidis meglumine | is modification of | True | tafamidis | Inferred relationship | Some | |
| Vyndaqel 20 mg capsule | has intended active ingredient | True | tafamidis | Inferred relationship | Some | 1500685992 |
| tafamidis meglumine 20 mg capsule | has intended active ingredient | True | tafamidis | Inferred relationship | Some | 1425475300 |
| tafamidis | has intended active ingredient | True | tafamidis | Inferred relationship | Some | 1909518656 |
| Vyndamax 61 mg capsule | has intended active ingredient | True | tafamidis | Inferred relationship | Some | 1635340269 |
| Vyndamax 61 mg capsule | has Australian BoSS | True | tafamidis | Inferred relationship | Some | 1635340269 |
| tafamidis 61 mg capsule | has Australian BoSS | True | tafamidis | Inferred relationship | Some | 83123199 |
| tafamidis 61 mg capsule | has intended active ingredient | True | tafamidis | Inferred relationship | Some | 83123199 |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
FHIR